LG-00034053

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameLG-00034053
Drug Alias NameLG-00034053
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCaspase inhibitors
TargetsCaspase
Therapy Area/IndicationsOsteoarthritis, Knee
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaSouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesLg Chemical Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLg Chemical Ltd
Inactive CompaniesN/A
Active IndicationsOsteoarthritis, Knee
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A